🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib and rituximab work in treatin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-08-28
Trial ID
NCT04047797
Treatments Being Tested
This is a two-part, non-randomized, open-label Phase I clinical study. The ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07169565
Treatments Being Tested
This phase Ib/II trial studies the best dose and safety of Bcl-2 inhibitor ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2015-08-03
Trial ID
NCT02427451
This phase II trial studies how well ibrutinib and rituximab work in treati...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2013-07-15
Trial ID
NCT01880567
Treatments Being Tested
This phase Ib trial tests the safety and effectiveness of tafasitamab, acal...
Status
Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2023-10-02
Trial ID
NCT05943496
This phase III trial compares adding a new anti-cancer drug (venetoclax) to...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-01-31
Trial ID
NCT03737981
Treatments Being Tested
Phase 2, two cohort trial evaluating the addition of ublituximab and umbral...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-08-05
Trial ID
NCT04016805
Treatments Being Tested
This phase II trial studies the side effects of an escalated ramp-up of son...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-06-02
Trial ID
NCT06839053
This phase II trial compares three chemotherapy regimens consisting of bend...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-12-13
Trial ID
NCT04115631
Treatments Being Tested
This study intends to use Obinutuzumab, Zanubrutinib, and Lenalidomide sequ...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2022-07-01
Trial ID
NCT05797948